Patents Represented by Attorney Leslie M. Levine

Find this attorney in the Justia Lawyer Directory

  • Effects of actin filaments of fibrin clot structure and lysis
    Patent number: 5691160
    Abstract: The present invention relates to therapeutic methods wherein an actin-binding protein, preferably gelsolin or DBP, is administered to a patient with actin-containing clots in order to remove actin from the clots. The invention also relates to diagnostic methods in which actin is removed from an actin-containing clot in vitro and quantitated.
    Type: Grant
    Filed: August 14, 1992
    Date of Patent: November 25, 1997
    Assignee: Biogen, Inc.
    Inventors: Paul A. Janmey, Jennifer A. Lamb, Stuart E. Lind, Thomas P. Stossel